SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001341004-14-000444
Filing Date
2014-05-21
Accepted
2014-05-20 20:36:50
Documents
5
Effectiveness Date
2014-05-21

Document Format Files

Seq Description Document Type Size
1 VALEANT PHARMACEUTICALS FORM S-8 forms8.htm S-8 109258
2 OPINION OF FARRIS, VAUGHAN, WILLS & MURPHY ex5_1.htm EX-5.1 13436
3 CONSENT OF PRICEWATERHOUSECOOPERS (US) ex23_1.htm EX-23.1 2657
4 CONSENT OF PRICEWATERHOUSECOOPERS (CANADA) ex23_2.htm EX-23.2 4268
5 graphic2.jpg GRAPHIC 26110
  Complete submission text file 0001341004-14-000444.txt   166941
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-196120 | Film No.: 14859431
SIC: 2834 Pharmaceutical Preparations